Donor-specific HLA antibody response in clonal deletion

Area of Science:

• Immunology
• Transplantation Science

Background:

• Post-transplant immunosuppression is standard to prevent antibody-mediated rejection.
• Clonal deletion protocols aim to induce immune tolerance by eliminating reactive lymphocytes.

Purpose of the Study:

• To evaluate the efficacy of a clonal deletion protocol without post-transplant immunosuppression.
• To assess the impact of donor-specific transfusion (DST) volume on donor-specific anti-HLA antibody (DSA) development.

Main Methods:

• A cohort of 61 patients underwent transplantation using a clonal deletion protocol.
• Patients received varying doses of DST (60 mL or larger) prior to transplantation.
• No planned post-transplant immunosuppression was administered.

Main Results:

• 48% of patients remained DSA-negative at a median follow-up of 158 days.
• Patients receiving a 60 mL DST had a significantly lower incidence of DSA (23%) compared to those receiving larger doses (68%).
• Lower DST volumes correlated with reduced specific immune responses and successful clonal deletion.

Conclusions:

• Limited DST volumes can promote tolerance and prevent DSA formation in clonal deletion protocols.
• The success of clonal deletion protocols may be enhanced by optimizing the DST dose.
• Further research into more effective deletion agents is warranted for improved transplantation outcomes.